- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/26 - Atomes de soufre
Détention brevets de la classe C07D 295/26
Brevets de cette classe: 362
Historique des publications depuis 10 ans
34
|
32
|
21
|
19
|
23
|
16
|
19
|
25
|
13
|
13
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Scripps Research Institute | 1351 |
16 |
The Regents of the University of California | 20153 |
14 |
FUJIFILM Corporation | 29713 |
9 |
Imago Biosciences, Inc. | 39 |
9 |
F. Hoffmann-La Roche AG | 7946 |
8 |
Canopy Growth Corporation | 223 |
8 |
Cytokinetics, Inc. | 284 |
8 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2886 |
7 |
H. Lundbeck A/S | 1250 |
7 |
Janssen Pharmaceutica N.V. | 3367 |
6 |
Board of Regents, The University of Texas System | 5891 |
6 |
University of Utah Research Foundation | 1827 |
6 |
3m Innovative Properties Company | 17762 |
5 |
Axikin Pharmaceuticals, Inc. | 14 |
5 |
Allergan Sales, LLC | 253 |
4 |
Emory University | 1643 |
4 |
Novira Therapeutics, Inc. | 32 |
4 |
Versitech Limited | 371 |
4 |
Genentech, Inc. | 4012 |
3 |
Centre National de La Recherche Scientifique | 10595 |
3 |
Autres propriétaires | 226 |